» Articles » PMID: 22402670

Regulating the Adaptive Immune Response to Respiratory Virus Infection

Overview
Journal Nat Rev Immunol
Date 2012 Mar 10
PMID 22402670
Citations 198
Authors
Affiliations
Soon will be listed here.
Abstract

Recent years have seen several advances in our understanding of immunity to virus infection of the lower respiratory tract, including to influenza virus infection. Here, we review the cellular targets of viruses and the features of the host immune response that are unique to the lungs. We describe the interplay between innate and adaptive immune cells in the induction, expression and control of antiviral immunity, and discuss the impact of the infected lung milieu on moulding the response of antiviral effector T cells. Recent findings on the mechanisms that underlie the increased frequency of severe pulmonary bacterial infections following respiratory virus infection are also discussed.

Citing Articles

Co-infections exacerbate inflammatory responses in COVID-19 patients, promoting coagulopathy and myocardial injury, leading to increased disease severity.

Chang X, Lai Y, Zhao Y, Zhao J, Zhang Y, Qian X Front Immunol. 2025; 16:1522313.

PMID: 40046064 PMC: 11879825. DOI: 10.3389/fimmu.2025.1522313.


A Primer on Proteomic Characterization of Intercellular Communication in a Virus Microenvironment.

Kostas J, Brainard C, Cristea I Mol Cell Proteomics. 2025; 24(3):100913.

PMID: 39862905 PMC: 11889360. DOI: 10.1016/j.mcpro.2025.100913.


Mucosal immune response in biology, disease prevention and treatment.

Zhou X, Wu Y, Zhu Z, Lu C, Zhang C, Zeng L Signal Transduct Target Ther. 2025; 10(1):7.

PMID: 39774607 PMC: 11707400. DOI: 10.1038/s41392-024-02043-4.


Host Innate and Adaptive Immunity Against African Swine Fever Virus Infection.

Zhang T, Lu Z, Liu J, Tao Y, Si Y, Ye J Vaccines (Basel). 2024; 12(11).

PMID: 39591181 PMC: 11599025. DOI: 10.3390/vaccines12111278.


Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies.

Muthukutty P, MacDonald J, Yoo S Vaccines (Basel). 2024; 12(11).

PMID: 39591123 PMC: 11598775. DOI: 10.3390/vaccines12111220.


References
1.
Snelgrove R, Godlee A, Hussell T . Airway immune homeostasis and implications for influenza-induced inflammation. Trends Immunol. 2011; 32(7):328-34. DOI: 10.1016/j.it.2011.04.006. View

2.
McGill J, van Rooijen N, Legge K . IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection. J Exp Med. 2010; 207(3):521-34. PMC: 2839152. DOI: 10.1084/jem.20091711. View

3.
Beauchamp N, Busick R, Alexander-Miller M . Functional divergence among CD103+ dendritic cell subpopulations following pulmonary poxvirus infection. J Virol. 2010; 84(19):10191-9. PMC: 2937786. DOI: 10.1128/JVI.00892-10. View

4.
Pang I, Iwasaki A . Inflammasomes as mediators of immunity against influenza virus. Trends Immunol. 2010; 32(1):34-41. PMC: 3017631. DOI: 10.1016/j.it.2010.11.004. View

5.
Yoo J, Galligan C, Virtanen C, Fish E . Identification of a novel antigen-presenting cell population modulating antiinfluenza type 2 immunity. J Exp Med. 2010; 207(7):1435-51. PMC: 2901068. DOI: 10.1084/jem.20091373. View